(Press-News.org) ITHACA, N.Y. - Cornell University research offers a number of alternatives to neonicotinoids (neonics) that might work for farmers who grow large-seeded vegetable crops such as snap bean, dry bean and sweet corn. This class of insecticides has devastating ecological impacts, especially to pollinators, beneficial insects and aquatic invertebrates.
“We wanted to find other options for growers to protect their vegetable crops from major pests. The impetus was to identify new products including those in the registration pipeline,” said Brian Nault, professor of entomology. “My program has shifted in recent years and has focused on this major issue.”
The task has not been easy, he added. “Insecticides kill insects, so it’s a tall order to find those that kill the pests but have minimal effects on pollinators and other beneficial insects.”
The race to find alternatives to neonicotinoids is urgent, Nault said, because the Birds and Bees Protection Act in New York state is phasing out the sale, distribution or purchase of certain neonicotinoid-treated corn, soybean or wheat seeds starting in the next few years.
Research shows neonics have made U.S. agriculture more harmful to insects, and the Environmental Protection Agency determined that neonics likely jeopardize the continued existence of more than 200 threatened and endangered species.
The researchers conducted field studies from 2021 to 2024 across Delaware, Minnesota, New York, Washington and Wisconsin. They compared protection of vegetable crops from seedcorn maggot using standard neonicotinoid seed treatments, thiamethoxam and clothianidin, with non-neonicotinoid alternatives including spinosad, cyantraniliprole, chlorantraniliprole, isocycloseram and tetraniliprole. They also compared the risk of these alternative insecticides to workers, consumers and the environment using the Environmental Impact Quotient (EIQ) developed by Cornell University's Integrated Pest Management Program.
They found that cyantraniliprole and spinosad seed treatments in snap bean performed as well and occasionally better than the neonicotinoid standard, thiamethoxam. None of the alternative insecticide seed treatments in dry bean provided consistent and reliable protection against seedcorn maggot compared with neonics. But the big triumph was that five different alternative seed treatments (chlorantraniliprole, cyantraniliprole, isocycloseram, spinosad and tetraniliprole) proved as effective as standard neonics for sweet corn.
“Sweet corn is a pretty big crop in New York state,” Nault said. So there is good news about alternatives for sweet corn, less so for dry beans and snap beans, he said. For all of the alternative pesticides, their research shows, supplemental options may be necessary to cover additional pests.
“For many vegetable crops, farmers could replace the neonic at planting but may need another pesticide later in the season,” Nault said. Other important factors will need to be considered before adopting non-neonicotinoid alternative seed treatments. For example, many are not yet approved for commercial use on these specific crops, and the cost of these newer products will undoubtedly be more expensive than neonicotinoids.
For additional information, read this Cornell Chronicle story.
-30-
END
Cornell researchers explore alternatives to harmful insecticide
2025-08-13
ELSE PRESS RELEASES FROM THIS DATE:
Fermentation method transforms unripe fruits into specialty coffees
2025-08-13
In the selection of specialty coffees, those that score above 80 points in blind tests are free of physical and sensory defects. Greenish-colored beans are known to give the drink an astringent taste, which is described as harsh, pungent, and dry. These beans are therefore discarded, along with broken, black, burnt, pitted, or undersized beans.
However, in a study published in the journal Food and Bioprocess Technology, researchers from the Federal University of Uberlândia (UFU) in Patos de Minas (state of Minas Gerais, Brazil) conducted a series of fermentations with ripe and ...
Oncology, primary care coordination necessary for best cancer patient outcomes
2025-08-13
Thanks to new advances in cancer care, more and more people are surviving cancer, with a projected total of 22.5 million survivors by 2032. The need for proper cancer survivorship care grows with each new case of remission, but according to new research from the University of Missouri School of Medicine, primary care could fill that need, given enough support.
Cancer survivorship care is complex, particularly after primary treatment has ended. Standard care addresses side effects from the treatment, encourages healthy lifestyle habits, discusses the patient's mental health, monitors cancer recurrence and screens for new cancers.
“Previous ...
Breakthrough discovery sparks new hope for breathing recovery after spinal cord injuries
2025-08-13
Today about 300,000 people nationally living with a spinal cord injury and with respiratory complications being the most common cause of illness and death, according to the Christopher & Dana Reeve Foundation.
But the results of a new study, led by researchers at Case Western Reserve University’s School of Medicine, show promise that a group of nerve cells in the brain and spinal cord—called interneurons—can boost breathing when the body faces certain physiological challenges, such as exercise and environmental conditions associated with altitude.
The researchers believe their discovery could ...
Can officials say what they need to say about a health emergency in 280 characters?
2025-08-13
Public health officials had an unprecedented tool for near-instant, widespread communication during the COVID-19 pandemic and mpox epidemic: social media.
Now, one of the first studies of its kind, led by a health policy expert with the Texas A&M University School of Public Health, has found that X (Twitter at the time of the events) brought advantages — as well as disadvantages — in getting the word out.
“For the year that the COVID-19 pandemic and mpox outbreak overlapped, we wanted to understand how health authorities in Chicago used X: the nature of the posts, what information was shared, how it was presented to the public and how all of that ...
United for answers: leading ALS organizations announce ‘Champion Insights’ to unlock why athletes and military members face higher ALS risk
2025-08-13
NEW ORLEANS, August 13, 2025 — Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie’s Quest, today announced plans to launch Champion Insights, an ambitious research initiative designed to uncover critical genetic and metabolic mechanisms that may explain the significantly higher incidence of amyotrophic lateral sclerosis (ALS) among endurance athletes, military service members, and potentially other high-performing populations.
ALS is a devastating neurodegenerative disease with no cure, affecting more than 5,000 Americans annually, and ...
Up to $5.2 million in federal funds will enable WashU to develop new biomanufacturing capabilities
2025-08-13
By Leah Shaffer
The process of biomanufacturing requires engineering microbes to produce useful chemicals and materials from carbon neutral processes. But current biomanufacturing cannot get beyond small production scale unless it can outcompete big oil.
The petrochemical industry produces chemicals and material building blocks at a low cost because these processes can run nonstop. However, performing microbial biomanufacturing continuously faces numerous challenges and presents a significant hurdle for economically viable bioproduction.
At the McKelvey School of Engineering at Washington University in St. Louis, researchers are ...
AI-informed approach to CAR design enhances bi-specific CAR T cells
2025-08-13
(MEMPHIS, Tenn. – August 13, 2025) A computational approach by St. Jude Children’s Research Hospital scientists promises to make designing T cell-based immunotherapies that target two cancer-related antigens at the same time far easier and faster. Chimeric antigen receptor (CAR) T cells are a type of immunotherapy that reprograms a patient’s immune cells to target a tumor-specific protein antigen. Targeting just one cell surface antigen often is not enough to eradicate the tumor. Thus, scientists ...
Discovery confirms early species of hominins co-existed in Ethiopia
2025-08-13
While we know much of the story of how humans evolved, the puzzle is still missing critical pieces. For example, fossil evidence for human evolution between 2 and 3 million years ago is patchy. It’s frustrating because we know that the branch of the hominin family tree that includes humans, or Homo sapiens, appears in the fossil record for the first time in this period.
Today, Homo sapiens (which anthropologists shorten to Homo), is the only hominin species alive. But in the past, Homo wasn’t alone. We coexisted and competed with other branches of the human family tree. Research ...
‘Controlled evolution’ dramatically boosts pDNA production for biomedical manufacturing
2025-08-13
Researchers have controlled the evolution of E. coli bacteria in the lab in order to dramatically increase the amount of plasmid DNA (pDNA) these modified bacteria produce. The advance is significant because pDNA is an essential – and expensive – ingredient in many gene therapies, and the new technique could drive down the cost of these medical treatments.
pDNA are found naturally in many bacteria and differ from other forms of DNA because the double helix shape most people are familiar with forms a circle, rather than the linear shape found in humans and most other organisms.
“pDNA is relatively easy to work with in the lab – it’s stable and easy ...
Ultrasound AI publishes landmark study demonstrating breakthrough in predicting delivery timing using AI and ultrasound images
2025-08-13
Ultrasound AI, a pioneer in artificial intelligence applications for medical imaging, today announced the publication of groundbreaking findings from its PAIR (Perinatal Artificial Intelligence in Ultrasound) Study in The Journal of Maternal-Fetal & Neonatal Medicine. The study was performed in collaboration with researchers at the University of Kentucky and validates Ultrasound AI’s proprietary technology that more accurately predicts time to delivery using only standard ultrasound images. This technology offers a non-invasive, efficient, and scalable tool ...